Corette B. Parker

Corette B. Parker

Auto-generated profile, based on publicly available information

Corette B. Parker

RTI International, United States

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2011 in Paediatric and Perinatal Epidemiology
Verified
Journal Article
Closed access
PDF file
CPCorette B. Parker
Corette B. Parker
CHCarol J. R. Hogue
Carol J. R. Hogue
MKMatthew A. Koch
Matthew A. Koch
MWMarian Willinger
Marian Willinger
URUma M. Reddy
Uma M. Reddy
FNfor the Stillbirth Collaborative Research Network
for the Stillbirth Collaborative Research Network

1 January 2010 in International Journal of Health Geographics
Verified
Journal Article
Open access
PDF file
NWNelli Westercamp
Nelli Westercamp
SMStephen Moses
Stephen Moses
KAKawango Agot
Kawango Agot
JNJeckoniah O Ndinya-Achola
Jeckoniah O Ndinya-Achola
CPCorette Parker
Corette Parker
RBRobert C Bailey
Robert C Bailey
The well-established connection between HIV risk behavior and place of residence points to the importance of geographic clustering in the potential transmission of HIV and other sexually transmitted infections (STI).

29 October 2003 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
CPCorette B. Parker
Corette B. Parker
EDElizabeth R. DeLong
Elizabeth R. DeLong

1 August 2017 in Annals of Epidemiology
Verified
Journal Article
Closed access
LCLauren Christiansen-Lindquist
Lauren Christiansen-Lindquist
RSRobert M. Silver
Robert M. Silver
CPCorette B. Parker
Corette B. Parker
DDDonald J. Dudley
Donald J. Dudley
MKMatthew A. Koch
Matthew A. Koch
CHCarol J.R. Hogue
Carol J.R. Hogue

4 February 2022 in Pregnancy Hypertension
Verified
Journal Article
Closed access
LTLauren H. Theilen
Lauren H. Theilen
PGPhilip Greenland
Philip Greenland
JVJasmina Varagic
Jasmina Varagic
JCJanet Catov
Janet Catov
ASAnthony Shanks
Anthony Shanks
RSRobert M. Silver
Robert M. Silver

6 January 2022 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
DSDavid B. Seifer
David B. Seifer
GMGeralyn Messerlian
Geralyn Messerlian
GPGlenn E. Palomaki
Glenn E. Palomaki
RSRobert M. Silver
Robert M. Silver
CPCorette Parker
Corette Parker
URUma M. Reddy
Uma M. Reddy
Background: Preeclampsia is characterized by decreased trophoblastic angiogenesis leading to abnormal invasion of spiral arteries, shallow implantation and resulting in compromised placentation with poor uteroplacental perfusion. Vitamin D plays an important role in pregnancy influencing implantation, angiogenesis and placental development. The objective of this study was to determine whether there is an association between serum vitamin D levels, and anti-angiogenic factors at the time of delivery and the occurrence of preeclampsia. Methods: This nested case control study analyzed frozen serum samples at the time of delivery and related clinical data from women with singleton liveborn pregnancies who had participated in studies of the NICHD Stillbirth Collaborative Research Network. Women with a recorded finding of preeclampsia and who had received magnesium sulfate treatment prior to delivery were considered index cases (N = 56). Women without a finding of preeclampsia were controls (N = 341). Results: Women with preeclampsia had 14.5% lower serum vitamin D levels than women in the control group (16.5 ng/ml vs. 19 ng/ml, p = 0.014) with 64.5% higher sFlt-1 levels (11,600 pg/ml vs. 7050 pg/ml, p < 0.001) and greater than 2 times higher endoglin levels (18.6 ng/ml vs. 8.7 ng/ml, < 0.001). After controlling for gestational age at delivery and maternal BMI, vitamin D levels were 0.88 times lower (P = 0.051), while endoglin levels were 2.5 times higher and sFlt-1 levels were 2.1 times higher than in control pregnancies (P < 0.001). Conclusions: Women with preeclampsia at time of delivery have higher maternal antiangiogenetic factors and may have lower maternal serum vitamin D levels. These findings may lead to a better understanding of the underlying etiology of preeclampsia as well as possible modifiable treatment options which could include assuring adequate levels of maternal serum vitamin D prior to pregnancy.